The effectiveness of a body mass reduction program in obese women in perimenopausal and menopausal age compared with the effectiveness of such a program in younger (18-44 years of age) women living in Poland.
The aim of the work was: to compare the effectiveness of body mass reducing program in women of perimenopausal (and menopausal) age with the effectiveness of such a program when it was applied to women aged 18-44 years.



The paper deals with observation study of the group of obese patients recruited and treated in Bialystok's Clinical Center for Cardiology and Body Mass Reduction. The authors summarize 12 months of clinical observation (as it was initially planned) of the two groups of obese women, taking part in the special body mass reduction program; Group I - 81 women in perimenopausal and menopausal age, Group II - 107 women in 18-44 years of age. The proposed treatment contained diet, physical exercises, psychological support and pharmacotherapy.



The positive reaction for the treatment of obesity was less visible in obese women in perimenopausal and menopausal age, than in the group of obese women in 18-44 years of age (change of BMI in the group of younger women was -3.44 kg/m2 vs. -2.65 kg/m2 in older women). As it was observed, the weaker reaction for the proposed treatment in the group of older women, was not related to lower BMR, than in the group of younger obese women. Provisional result shows that use of HRT (Hormonal Replace Therapy) may probably result in better response of body mass reduction in perimenopausal and menopausal women.



The high dropout of the patients included into the study does not allow to formulate unequivocal conclusions but it seems that body mass reduction program for women in perimenopausal and menopausal age should concentrate on building the motivation of the patients, HRT may play some role in improvement of effectiveness of such program but this should be confirmed by further studies.
Ostrowska
L
L
Department of Hygiene and Epidemiology in Medical University of Bialystok, Poland.
Lech
M M
MM
D000293:Adolescent; D000328:Adult; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D002149:Energy Intake; D015444:Exercise; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D047648:Perimenopause; D011044:Poland
D019440:Anti-Obesity Agents